BMEA BioMea Fusion, Inc.
BioMea Fusion, Inc. (BMEA) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: December 11, 2025 , by Erdtmann Rainer M .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Erdtmann Rainer M | See Remarks | Buy | 30,000 | $1.43 | $43.0K | 723,027 | |
| Hitchcock Michael J.M. | Interim CEO | Buy | 100,000 | $0.99 | $99.2K | 115,000 | |
| Erdtmann Rainer M | See Remarks | Buy | 10,000 | $1.05 | $10.5K | 693,027 | |
| Erdtmann Rainer M | See Remarks | Buy | 40,000 | $1.10 | $44.1K | 683,027 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.